Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): Effects of administration of Zidovudine in vivo and interleukin-2 in vitro

Author： Pierdominici M.   Mollicone B.   Ricci G.   Oliva A.   D'Offizi G.   Giovannetti A.   Aiuti F.   Pandolfi F.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.16, Iss.7, 1998-04, pp. : 715-721

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein

By Gorse G.J.   Patel G.B.   Newman F.K.   Mandava M.   Belshe R.B.  

Vaccine, Vol. 13, Iss. 13, 1995-01 ,pp. : 1170-1179

Elsevier

Access to resources Recommend Favorite

Modulation of immunologic responses to HIV-1 MN recombinant gp160 vaccine by dose and schedule of administration

By National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group   Gorse G.J.   McElrath M.J.   Matthews T.J.   Hsieh R.-H.   Belshe R.B.   Corey L.   Frey S.E.   Kennedy D.J.   Walker M.C.   Eibl M.M.  

Vaccine, Vol. 16, Iss. 5, 1998-03 ,pp. : 493-506

Elsevier

Access to resources Recommend Favorite

Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 Env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)

By Morris C.B.   Cheng E.   Thanawastien A.   Cardenas-Freytag L.   Clements J.D.  

Vaccine, Vol. 18, Iss. 18, 2000-03 ,pp. : 1944-1951

Elsevier

Access to resources Recommend Favorite

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva

By NIAID AIDS   Gorse G.J.   Rogers J.H.   Perry J.E.   Newman F.K.   Frey S.E.   Patel G.B.   Belshe R.B.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 209-214

Elsevier

Access to resources Recommend Favorite

Molecular basis of the inefficacy and possible harmful effects of AIDS vaccine candidates based on HIV-1 envelope glycoprotein gp120

By Veljkovic V.   Johnson E.   Metlas R.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 473-474

Elsevier

Access to resources Recommend Favorite